Andrea Anderson
Andrea Anderson covers genomics research studies and translational research for GenomeWeb. Find her on Twitter at @andyandy_tk.

Articles Authored by Andrea Anderson
Cancer Immunotherapy Response Linked to Gut Microbes in Multiomic Analysis
Researchers found gut microbes and metabolites linked to pan-cancer immune checkpoint blockade responses, highlighting five distinct enterotypes.

Researchers narrowed in on dual-treatment targets using expression and regulatory programs found in glioblastoma cells in and around the tumor.
In an indirect comparison study by researchers in Germany, a fecal immunochemical test showed similar sensitivity and specificity as Exact Sciences' Cologuard Plus test.
Breast Cancer Study Highlights Germline Genetic Influence on Tumor Subtype, Aggressiveness
Investigators saw relationships between germline epitope burdens in frequently amplified driver genes and immunoediting-related breast cancer features.
Neoantigen Detection Platform Picks up T-Cell Responses to Tumor Mutations
Researchers combined tumor sequence, transcriptome, and patient immune cell response clues in their tumor-specific neoantigen detection and validation platform.
All of Us Data Leads to New Genetic Variants, Disease Risk Contributors
A collection of papers has provided a look at findings from the All of Us Research Program's release of 245,388 clinical-grade genome sequences.
Hodgkin Lymphoma Subtypes, Treatment Response Untangled with Liquid Biopsy Assays
Researchers used circulating tumor DNA to characterize subtypes of classic Hodgkin lymphoma, treatment responses, and residual disease markers portending potential relapse.
Ovarian Cancer Detected Early With DNA From Pap Smear in Proof-of-Principle Study
Researchers developed an early ovarian cancer test based on DNA from Pap smears from women who went on to develop high-grade serous ovarian cancer.
Breast Cancer Risk Genes Unearthed in Exome Sequence Meta-Analysis
Researchers tracked down a handful of previously unappreciated susceptibility genes using exome sequences for more than 244,000 European women with or without breast cancer.
COVID-19 Protection Provided by HLA Genetic Variant, Study Suggests
Using data from bone marrow registry participants, researchers found an HLA variant linked to symptom-free SARS-CoV-2 infection and better immune cell responses.
